Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Sertraline in the Treatment of Generalized Social Phobia with Comorbidity.

Trial Profile

Sertraline in the Treatment of Generalized Social Phobia with Comorbidity.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 26 Mar 2018

At a glance

  • Drugs Sertraline (Primary)
  • Indications Social phobia
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Mar 2018 Status changed from active, no longer recruiting to discontinued as the study drug could not be re-supplied.
    • 21 Mar 2017 Planned End Date changed from 1 Mar 2017 to 1 Mar 2018.
    • 21 Mar 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Jan 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top